Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
JAMA Oncology
|
March 13, 2020
Metformin Plus Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer-Reply
Oscar Arrieta, Laura Alejandra Ramirez-Tirado, Zyanya Lucia Zatarain-Barrón
Journal of Thoracic Disease
|
June 1, 2018
Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an <i>EGFR</i> mutation
Feliciano Barrón, Andrés F Cardona, Luis Corrales, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Laura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Laura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 13, 2026
Biomarkers
Laura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Laura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Cancer Medicine
|
February 12, 2020
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer
Oscar Arrieta, Alejandro Aviles-Salas, Mario Orozco-Morales, et al.
The Lancet. Public Health
|
January 29, 2026
The effect of Indigenous American genomic ancestry on type 2 diabetes in Mexico: an analysis of 134 548 individuals from the Mexico City Prospective Study
Jaime Berumen, Pablo Kuri-Morales, Jason M Torres, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
JAMA Oncology
|
March 13, 2020
Metformin Plus Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer-Reply
Oscar Arrieta, Laura Alejandra Ramirez-Tirado, Zyanya Lucia Zatarain-Barrón
Journal of Thoracic Disease
|
June 1, 2018
Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an <i>EGFR</i> mutation
Feliciano Barrón, Andrés F Cardona, Luis Corrales, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Laura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Laura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 13, 2026
Biomarkers
Laura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Laura Alejandra Ramirez Tirado, Ann D Cohen, C Elizabeth Shaaban, et al.
Cancer Medicine
|
February 12, 2020
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer
Oscar Arrieta, Alejandro Aviles-Salas, Mario Orozco-Morales, et al.
The Lancet. Public Health
|
January 29, 2026
The effect of Indigenous American genomic ancestry on type 2 diabetes in Mexico: an analysis of 134 548 individuals from the Mexico City Prospective Study
Jaime Berumen, Pablo Kuri-Morales, Jason M Torres, et al.
Page
of 1